NeuroSense Therapeutics Ltd. (NRSN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

25.48M

Year ended 2025-12-31

+30.4%

3-year compound annual growth

2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Period ended	Weighted Average Diluted Shares	Change YoY	Source filing
2025-12-31	25.48M	+37.0%	2026-03-31, From 2025-01-01
2024-12-31	18.60M	+36.4%	2026-03-31, From 2024-01-01
2023-12-31	13.64M	+18.6%	2026-03-31, From 2023-01-01
2022-12-31	11.50M	n/a	2025-04-07, From 2022-01-01